Table 4.
Outcome and overall survival data according to the treatment in 19 intradural extramedullary spinal metastases from RCC.
| Treatment | Clinical Outcome | Overall Survival | |||||
|---|---|---|---|---|---|---|---|
| Stable | Improved | Worsened | n.s. | Alive (Months) | Dead | n.s. | |
| Surgery alone (5/19) | 0 | 5 | 0 | 0 | 2 (20–24 mo.) (Mean 22 ± 2.8 SD mo.) |
1 (Mean 22 ± 2.8 SD mo.) |
2 |
| Adjuvant radiotherapy (8/19) | 1 | 7 | 0 | 0 | 7 (12–108 mo.) (Mean 32 ± 37.7 SD mo.) |
1 (12 mo.) | 0 |
| Adjuvant chemotherapy (2/19) | 1 | 1 | 0 | 0 | 1 (12 mo.) | 0 | 1 |
| Adjuvant IFN therapy (2/19) | 0 | 1 | 1 | 0 | 2 (12–36 mo.) (Mean 24 ± 16.9 SD mo.) |
0 | 0 |
| Adjuvant radio and chemotherapy (2/19) | 0 | 1 | 1 | 0 | 1 (12 mo.) | 1 (1 mo.) | 0 |
| Chemotherapy alone (1/19) | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
n.s.: not specified, mo.: months.